797 related articles for article (PubMed ID: 14768298)
1. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
2. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
3. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
4. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
5. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Ullmann AJ
Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole: review of a broad spectrum triazole antifungal agent.
Kofla G; Ruhnke M
Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
[TBL] [Abstract][Full Text] [Related]
7. New antifungal drugs and new clinical trials: interpreting results may be difficult.
Girmenia C; Martino P
Curr Opin Oncol; 2003 Jul; 15(4):283-8. PubMed ID: 12874505
[TBL] [Abstract][Full Text] [Related]
8. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
10. [Systemic antifungal agents].
Lumbreras C; Lizasoain M; Aguado JM
Enferm Infecc Microbiol Clin; 2003; 21(7):366-79; quiz 380, 390. PubMed ID: 14525693
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin: first approved agent in a new class of antifungals.
Johnson MD; Perfect JR
Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
[TBL] [Abstract][Full Text] [Related]
12. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin: a review of its use in the treatment of fungal infections.
McCormack PL; Perry CM
Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
[TBL] [Abstract][Full Text] [Related]
14. Management of invasive mycoses in hematology patients: current approaches.
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
[TBL] [Abstract][Full Text] [Related]
15. New options for the treatment of invasive fungal infections.
Rubin ZA; Somani J
Semin Oncol; 2004 Apr; 31(2 Suppl 4):91-8. PubMed ID: 15124141
[TBL] [Abstract][Full Text] [Related]
16. [Efficacies and clinical roles of new antifungal agents].
Tokimatsu I; Kadota J
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948
[TBL] [Abstract][Full Text] [Related]
17. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
18. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Spanakis EK; Aperis G; Mylonakis E
Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621
[TBL] [Abstract][Full Text] [Related]
19. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin acetate for treatment of invasive fungal infections.
Pacetti SA; Gelone SP
Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]